Graeme Bell
Interim Chief Executive Officer
Leadership
Company
We are driven to find better, bolder approaches to drug discovery that will ultimately transform the way we think about disease. We are Valo.
Graeme Bell
Interim Chief Executive Officer
Leadership
Michael Graziano, PhD
SVP, Chief Scientific Officer
Chris Schade
Executive Chairman of the Board of Directors
Brett Blackman, PhD
SVP, Chief Business Officer
Leadership
Harsha Ramalingam, MBA
Board Director
P. Adam Smalley
Board Director
Guido Lanza
SVP, Chief Technology Officer
Ron Hovsepian
Board Director
Jeffrey Prowda, JD
SVP, Chief Legal Officer & General Counsel
Leadership
Paul Biondi, MBA
Board Member
Victor Shi, MD
SVP, Chief Medical Officer
Lisa Young
Board Director
David Mauney, MD
Board Director
Moni Miyashita
EVP, Chief Strategy Officer
Leadership
David R. Epstein
Board Director